Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,035
archived clinical trials in
Bipolar Disorder

Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Garden Grove, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Long Beach, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Oceanside, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Pico Rivera, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Washington,
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Bradenton, FL
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Maitland, FL
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Topeka, KA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Lake Charles, LA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Shreveport, LA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Flowood, MS
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Flowood, MS
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
St. Louis, MO
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Willingboro, NJ
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Willingboro, NJ
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Dayton, OH
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Charleston, SC
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Austin, TX
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Austin, TX
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Dallas, TX
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Dallas, TX
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated:  4/22/2014
Clinical Research Facility
mi
from
Salt Lake City, UT
Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692)
A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine in Subjects Diagnosed With Bipolar 1 Disorder Who Completed Protocol P05691 (Formerly 041044) (Phase3B, Protocol P05692 [Formerly 041045])
Status: Enrolling
Updated: 4/22/2014
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder
Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder
Status: Enrolling
Updated:  4/30/2014
University of California at Los Angeles
mi
from
Los Angeles, CA
Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder
Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder
Status: Enrolling
Updated: 4/30/2014
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
Determination of Adherence in Patients Admitted to a Psychiatric Unit for Decompensated Psychosis: an Analysis of Serum Levels of Antipsychotics.
Status: Enrolling
Updated:  5/12/2014
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
Determination of Adherence in Patients Admitted to a Psychiatric Unit for Decompensated Psychosis: an Analysis of Serum Levels of Antipsychotics.
Status: Enrolling
Updated: 5/12/2014
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Medical Center, Birmingham, AL
mi
from
Birmingham, AL
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Medical Center, Birmingham, AL
mi
from
Birmingham, AL
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Medical Center, Tuscaloosa, AL
mi
from
Tuscaloosa, AL
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Medical Center, Tuscaloosa, AL
mi
from
Tuscaloosa, AL
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Central Arkansas VHS Eugene J. Towbin Healthcare Center, Little Rock, AR
mi
from
No. Little Rock, AR
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Central Arkansas VHS Eugene J. Towbin Healthcare Center, Little Rock, AR
mi
from
No. Little Rock, AR
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Long Beach Healthcare System, Long Beach, CA
mi
from
Long Beach, CA
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Long Beach Healthcare System, Long Beach, CA
mi
from
Long Beach, CA
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA San Diego Healthcare System, San Diego, CA
mi
from
San Diego, CA
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
mi
from
West Haven, CT
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
mi
from
West Haven, CT
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Washington DC VA Medical Center, Washington, DC
mi
from
Washington,
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Medical Center, Miami
mi
from
Miami, FL
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Medical Center, Miami
mi
from
Miami, FL
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
mi
from
Baltimore, MD
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Boston Healthcare System Brockton Campus, Brockton, MA
mi
from
Brockton, MA
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Boston Healthcare System Brockton Campus, Brockton, MA
mi
from
Brockton, MA
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
VA Central Western Massachusetts Healthcare System, Leeds, MA
mi
from
Leeds, MA
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
VA Central Western Massachusetts Healthcare System, Leeds, MA
mi
from
Leeds, MA
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Franklin Delano Roosevelt Campus of the VA Hudson Valley Health Care System, Montrose, NY
mi
from
Montrose, NY
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Franklin Delano Roosevelt Campus of the VA Hudson Valley Health Care System, Montrose, NY
mi
from
Montrose, NY
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
mi
from
Salisbury, NC
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
mi
from
Salisbury, NC
Click here to add this to my saved trials
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated:  6/9/2014
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
Status: Enrolling
Updated: 6/9/2014
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
Click here to add this to my saved trials